Zanfina Ademi Delaney

Professor Zanfina Ademi Delaney is a Professor of Health Economics at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, leading the Health Economics and Policy Evaluation Research (HEPER) Group. She specializes in health technology assessment (HTA), economic evaluations, and decision modeling, with a focus on cardiovascular disease prevention and genomic screening. Her work has informed global healthcare policies, attracting $45M in research funding. She holds adjunct roles at the University of Eastern Finland and serves on key committees like Australia’s PBAC Economics Sub-Committee and the Lp(a) International Task Force.

Education:

• PhD in Health Economics & Epidemiology, Monash University (2011)
• MPH in Public Health & Epidemiology, University of Eastern Finland (2006)
• MPharm, University of Medicine Tirana (2003)

Research Interests: Her groundbreaking work includes developing metrics like Productivity Adjusted Life Years (PALYs) and the HEM-PPCVD model for cardiovascular prevention. She integrates Mendelian Randomisation into economic evaluations to address long-term prevention challenges. Her research spans chronic disease modeling, cost-effectiveness analysis, and health equity.

Awards:

• Best General Podium Presentation (ISPOR, 2019)
• Best Poster (HBPRCA, 2009)
• Outstanding Peer Support (2011)

Grants & Advising: Leads 24+ funded projects, including $45M in NHRMC/MRFF grants. Advises on epilepsy treatment selection (PERSONAL Trial) and antenatal care in Nepal (IpreventNCD). Supervises PhD students via Monash’s SupervisorConnect program.

Labs/Teams: HEPER Group at Monash and collaborations with the Florey Institute, University of Basel, and international HTA networks. Her work bridges academia and policy, influencing global healthcare funding decisions.